# FDA recall D-0851-2021

> **Viatris** · Class II · drug recall initiated 2021-08-23.

## Product

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0851-2021
- **Recalling firm:** Viatris
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-08-23
- **Report date:** 2021-10-06
- **Termination date:** 2022-09-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morgantown, WV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0851-2021

## Citation

> AI Analytics. FDA recall D-0851-2021. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0851-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*